Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Folate and breast cancer

This article was originally published in The Tan Sheet

Executive Summary

"Sufficient dietary intake of folate" may mitigate the increased risk of breast cancer associated with alcohol consumption, an Aug. 8 British Medical Journal study finds. Laura Baglietto, Cancer Epidemiology Centre, Melbourne, et al., used data on diet and alcohol consumption gathered from 17,447 women through the Melbourne collaborative cohort study from 1990-1994. Participants were followed until Dec. 31, 2003, and breast cancer cases were identified through the Victorian cancer registry. "Compared with abstainers who consumed 200 mg/day of folate, the hazard ratio was two-fold higher for those women who consumed the most alcohol (40 g/day or more)," Baglietto et al. observe. Women with high alcohol consumption and low folate intake had an increased risk of breast cancer, while those with high alcohol consumption and moderate or high folate intake had no increased risk, the authors conclude...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel